Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 (2023)
Source: ACS Omega. Unidade: IFSC
Subjects: COVID-19, PEPTÍDEOS, AGENTES ANTIMICROBIANOS, PLANEJAMENTO DE FÁRMACOS
ABNT
PUHL, Ana Cristina et al. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2. ACS Omega, v. 8, n. 25, p. 22603-22612, 2023Tradução . . Disponível em: https://doi.org/10.1021/acsomega.3c01110. Acesso em: 06 nov. 2024.APA
Puhl, A. C., Godoy, A. S. de, Noske, G. D., Nakamura, A. M., Gawriljuk, V. O., Fernandes, R. S., et al. (2023). Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2. ACS Omega, 8( 25), 22603-22612. doi:10.1021/acsomega.3c01110NLM
Puhl AC, Godoy AS de, Noske GD, Nakamura AM, Gawriljuk VO, Fernandes RS, Oliva G, Ekins S. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 [Internet]. ACS Omega. 2023 ; 8( 25): 22603-22612.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1021/acsomega.3c01110Vancouver
Puhl AC, Godoy AS de, Noske GD, Nakamura AM, Gawriljuk VO, Fernandes RS, Oliva G, Ekins S. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 [Internet]. ACS Omega. 2023 ; 8( 25): 22603-22612.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1021/acsomega.3c01110